Europass CV - umfcd



|INFORMAŢII PERSONALE |DAN GHEORGHE-ANDREI |

| |

|[pic] | |

| | |

| | |

| | |

|EXPERIENŢA PROFESIONALĂ |[pic] |

|2006 - prezent |Profesor universitar, Departamentul 5 “Medicina Interna” Universitatea de Medicina si Farmacie “Carol Davila” |

| |Seful Clinicii/Disciplinei de Medicina Interna, Spitalul Clinic Colentina |

| |Seful Sectiei Clinice de Cardiologie , Explorari Cardiovasculare si Ritmologie, Spitalul Clinic Colentina |

| |Cercetator St. Gr. 1 (hon) |

| | |

| | |

| | |

| | |

| | |

| | |

| | |

| |Universitatea de Medicină şi Farmacie „Carol Davila” |

| |Dionisie Lupu, nr.37, sector 1, Bucureşti, 020022, Romania |

| |Invatamant universitar, anii : 4, 5, 6 (cardiovascular, optional, urgente medicale) (cursuri + lucrari |

| |practice/seminarii) |

| |Invatamant postuniversitar, coordonator studii doctorale |

| |Cercetare |

| |Invăţământ pentru medicii rezidenţi |

| |Tipul sau sectorul de activitate : Invătământ medical |

|2004- prezent |Expert evaluator |

| |Expert evaluator pentru granturi CNCSIS, CNMP şi pentru granturi de excelenţă CEEX |

| 2000-2006 |Conferenţiar universitar |

| |Invăţământ superior şi cercetare ştiinţifică |

|2002-prezent |Medic primar cardiolog |

|2001 |Cercetător ştiinţific gr.I |

| |Cercetare ştiinţifică |

| 2000 - prezent |Cardiolog european (ISCED 6) |

| |European Board for the Specialty of Cardiology |

|1996 - 2000 |Sef de lucrări |

|1990 - 1996 |Asistent universitar |

|1998 |Doctor în medicină (ISCED 6) |

|1991 |Medic primar medicină internă (ISCED 6) |

|1977 |Doctor – medic (ISCED 5) |

|EDUCAŢIE ŞI FORMARE |[pic] |

|DATA | |Nivel EQF |

| | |

|2003 |Curs intensiv postuniversitar: “Cardiology Summit Training, Harvard Medical School” - 8 |

|2000 |Training in Studii Clinice (Hong-Kong) |

|1998 |Doctor in medicina cu teza “Locul electrofiziologiei interventionale in tratamentul tahicardiilor simptomatice”|

|1996 |Pregatire post-universitara “Good Clinical Practice“ (Praga) |

|1995 |Supraspecializare in ritmologie interventionala - Université Catholique de Louvain-Cliniques Universitaires de |

| |Mont-Godinne, Belgia |

|1993-1995 |Specializare postuniversitara in Ritmologie Interventionala – Université Catholique de Louvain - Cliniques |

| |Universitaires de Mont-Godinne, Belgia |

|1993-1996 |Pregatire postuniversitara cardiologie |

|1989-1990 |Curs postuniversitar cardiologie |

|1988 |Curs postuniversitar de Pedagogie medicala |

|1980-1984 |Asistent universitar – secundariat de medicina interna |

|1976-1980 |Intern de medicina interna |

|1971-1977 |Facultatea de Medicina Generala, Institutul de Medicina si Farmacia « Carol Davila » Bucuresti |

|COMPETENΤE PERSONALE |[pic] |

|Limba maternă | Română |

| | |

|Alte limbi străine cunoscute |ΙNΤELEGERE |VORBIRE |SCRIERE |

| |Ascultare |Citire |Participare la |Discurs oral | |

| | | |conversaţie | | |

|Limba engleză |C2 Utilizator |C2 Utilizator |C2 Utilizator |C2 Utilizator |C2 Utilizator |

| |experimentat |experimentat |experimentat |experimentat |experimentat |

|Limba franceză |C2 Utilizator |C2 Utilizator |C2 Utilizator |C2 Utilizator |C2 Utilizator |

| |experimentat |experimentat |experimentat |experimentat |experimentat |

| |Niveluri: A1/2: Utilizator elementar - B1/2: Utilizator independent - C1/2: Utilizator experimentat |

| |Cadrul european comun de referinţă pentru limbi străine |

|Activitate redactionala stiintifica |Redactor Sef – Romanian Journal of Internal Medicine |

| |Associate Editor – Journal of the Royal Society of Medicine – Cardiovascular |

| |Associate Editor – International Journal of Cardiology _ Heart & Vasculature |

| |Editorial Board: Cardiovascular Drugs and Therapy, Springer |

| |Editorial Board: European Cardiology Review (ECR) |

| |Membru Editorial Board American Journal of Therapeutics |

| |Membru in Editorial Board: Cardiovascular Drugs and Therapy |

| |Membru in comitetul editorial “Medicina Interna” |

| |Membru Editorial Council “Romanian Journal of Cardiology |

| |Member of Clinical Cardiology Council of American Heart Association/ American Stroke Association - from 1999 |

| |Member of Council on Arteriosclerosis, Thrombosis and Vascular Biology of AHA/ASA |

| |Member of Interdisciplinary Working Group on Atherosclerotic Peripheral Vascular Disease of AHA/ASA |

| |Membru in boardul redactional Journal of Hypertension Research |

| | |

| |Peer Reviewer (principale) |

| |International Journal of Cardiology |

| |European Journal of Cardiology |

| |Europace |

| |American Journal of Therapeutics |

| |Radcliffe: Arrhythmias and Electrophysiology Reviews (AER) |

| |Radcliffe: European Cardiology Reviewes |

| |Chest |

| |Drugs of the future (Prous Thompson Reuters) |

| |Acta Endocrinologica |

|Alte specializări şi calificări |Director fondator si organizator al simpozionului international “Heart Rhythm Update” (2007, 2009, 2011, 2016, |

| |2019) |

| |Co-Chair al Congresului XVIII International Society of Cardiovascular Pharmacotherapy, Roma 2013 |

| |Chair al Congresului XIX International Society of Cardiovascular Pharmacotherapy, Adelaide, 2014 |

| |Co-chair Congresului XX International Society of Cardiovascular Pharmacotherapy, Buenos Aires 2015 |

| |Investigator principal in 30 studii multicentrice internationale si 4 studii multicentrice nationale |

| |Coordonator National: 6 studii multicentrice |

| |Organizator al unui numar de peste 15 cursuri internationale – incepand din 1997 |

| |Cofondator al parteneriatului medical “Université Catolique de Louvain – Cliniques Universitaires de |

| |Mont-Godinne – Spitalul Clinic “N.Gh.Lupu” |

|Competenţe organizaţionale/manageriale |„Sprijinirea cercetării prin formarea de specialiști în cadrul programului de studii postdoctorale”. Numărul de|

| |identificare a contractului: POSDRU/89/1.5/S/64109 – 2015- expert |

| |“Cercetarea doctorala si postdoctorala – prioritate a invatamantului superior romanesc”. Nr. de identificare a |

| |proiectului POSDRU 151/1.5/S/137390 - formator |

| |Atrial fibrilllation general pilot registry (2009 - 2015). Coordonator national si membru al “steering |

| |committee” |

| |Atrial fibrillation general long-term registry (2009 - in curs). Coordonator national si membru al “steering |

| |committee” |

| |Heart failure long-term registry (2009 - in curs). Coordonator national si membru al “steering committee” |

| |The BALKAN-AF Survey (2015). Coordonator national si membru al “steering committee” |

| |Fondator al Programului si Registru si constientizare in fibrilatia atriala FACTS (primul spot –registry de |

| |fibrilatie atriala in Romania) |

| |Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe. Country leaders: |

| |Gheorghe-Andrei Dan, Dan Gaita. Vnitř Lék 2017; 63(1); ISSN 0042-773X (print), ISSN 1801-7592 (online) |

|Alte activitati profesionale |Seful sectiei clinice de cardiologie din Spitalul Clinic Colentina |

| |Infiintarea si organizarea laboratorului de explorari functionale cardiovasculare din Spitalul Clinic Colentina|

| |Infiintarea si organizarea laboratorului de electrofiziologie invaziva din Spitalul Clinic Colentina |

| |Infiintarea centrului de sincopa din Spitalul Clinic Colentina |

| |Membru al Consiliului stiintific din Spitalul Clinic Colentina |

| |Presedintele Comisiei de etica a cercetarii din Spitalul Clinic Colentina |

| |Membru in board CMB (coordonator comisia litigii) |

|Membru in comitete de organizare |SPAF Academy, Viena, ianuarie 2013 |

| |Al 9-lea Congress ECAS, Paris, aprilie 2013 |

| |Conferinta de Biotehnologie, Atena, 30.V. – 2.VI.2013 |

| |Joint symposium ISCP and IKEM Institute of Clinical and Experimental Medicine. Praga, iunie 2013 |

| |“Stroke prevention” curs. Decembrie 2013, Londra |

| |Al Xlea CVCT Forum 2013, Paris |

| |Simpozion International organizat de ISCP la Praga, martie 2014 |

| |Al 10-lea Congres ECAS, Munchen, 2014 |

| |Congresul WCC – Melbourne, mai 2014 |

| |Management of HT, AF and stroke . Curs international ISCP/MICOM, Budapesta, iunie 2014 |

| |Management of heart and pulmonary diseases. Curs international ISCP/MICOM, Bucuresti, iunie 2014 |

| |In the eye of the expert, Simpozion Jubiliar KRKA, 60 ani, Slovenia, septembrie 2014 |

| |CEE hyperlipidemia Academy, Praga, octombrie 2014 |

| |Al XIlea CVCT Forum Washington, decembrie 2014 |

| |Thrombus Forum, Sinaia, mar. 2015 |

| |NOAC Regional Forum, Sinaia, apr. 2015 |

| |SPAF Regional speaker workshop, Praga, mai 2015 |

| |ESC Congress, Londra, aug-sep. 2015 |

| |SPAF Academy VII, Sinaia, feb. 2016 |

| |SPAF Academy Regional, Baile Felix, apr. 2016 |

| |Congres ISCP, Beijing, oct. 2016 |

| |Congres ISCP, Barcelona, 24-25.08.2017 |

|Aparteneţe la organizaţii profesionale |Membru de onoare al Societatii Romane de Cardiologie |

| |Past-President – Executive Committee Chair: International Society of Cardiovascular Pharmacotherapy affiliated |

| |to World Heart Federation |

| |Fellow of the American Heart Association/American Stroke Association ( FAHA) – titlu curricular |

| |Fellow of the European Society of Cardiology (FESC)- titlu curricular |

| |Fellow of the European Heart Rhythm Association (FEHRA) – titlu curricular |

| |Fellow of the American College of Cardiology (FACC) – titlu curricular |

| |Premium-Plus Professional, Silver Member of American Heart Council |

| |European Heart Rhythm Association (EHRA): Scientific Initiative Committee Board |

| |European Heart Rhythm Association (EHRA): National Societies Committee – Founder Member |

| |EuroObservational Research Programe – Atrial Fibrillation Registry: Executive Committee |

| |Board of Directors: International Society of Cardiovascular Pharmacotherapy |

| |Cardiolog European (acreditat de European Board for the Speciality of Cardiology)Association / American Stroke |

| |Association (since 1999) |

| | |

|INFORMAΤII SUPLIMENTARE |[pic] |

| | International Cardiovascular Summit, Harvard Medical School, |

| |Diploma for participation in EuroHeart Survey, |

| |Diploma de “Expert in Evaluation of Scientific Grants” (Ministerul educatiei si Cercetarii) |

|Distincţii |Award distinction for outstanding Contribution : Romanian Nephrology Society |

|Premii |Special prize of the Romanian Society of Internal Medicine for Interdisciplinary Collaboration |

| |Medal and award Diploma International Society of Cardiovascular Pharmacotherapy 2014 |

| |Award Diploma ISCP 2015 |

| |Award Diploma: EHRA Scientific Documents Committee |

| |The Brain Networking Foundation Prize, 2016 |

| | |

|Experienţa acumulată |Studierea sistemului biologic integrativ reprezentat de efectul cardiovascular al obezităţii, prin utilizarea |

|(în special managerială) în alte |unor tehnici ecografice, scintigrafice şi de modelare matematică, în vederea definirii cardiomiopatiei |

|programe/proiecte |specifice obezităţii şi a predicţiei insuficienţei cardiace. (nr. Contract 41-061 Parteneriate PN II) – |

|naţionale/internaţionale |Director de proiect |

| |“Cariera de excelenta in cercetare si societatea cunoasterii prin finantarea studiilor universitare de doctorat|

| |(EXCEL-FIN)”. Nr. de identificare a proiectului POSDRU/107/1.5/S/82839 – Manager de proiect |

| |„Sprijinirea cercetării prin formarea de specialiști în cadrul programului de studii postdoctorale”. Numărul de|

| |identificare a contractului: POSDRU/89/1.5/S/64109 – expert |

| | |

| |Studii multicentrice (IP, coordonator national, membru Steering Committee) |

| |Effects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A |

| |randomized double-blind placebo-controlled international multicenter study (SIGNIFY). Protocol No. |

| |CL3-16257-083 (2011-2014) |

| |Efficacy of Ranolazine in patients with coronary artery disease (CAD). Protocol No. MEIN/10/Ran-Cad/003 |

| |(2013-2015). Investigator national |

| |A double-blind, randomized, placebo-controlled, multicenter study assessing the impact of additional |

| |LDL-Cholesterol reduction on major cardiovascular events when AMG145 is used in combination with statin therapy|

| |in patients with clinically evident cardiovascular disease. Protocol No. 20110118. (2012 – 2017). Investigator |

| |national si membru in “steering committee” |

| |Prospective observational longitudinal registry of patients with stable coronary artery disease (CLARIFY) |

| |(2015-2015) |

| |A prospective, randomized, open-label, blinded endpoint evaluation (PROBE) parallel group study comparing |

| |eduxaban (DU-176b) with enoxaparin/warfarin followed by warfarin alone in subjects undergoing planned |

| |electrical cardioversion of non-valvular atrial fibrillation. Protocol No. DU176b-F-E308 (2014-2015). |

| |Investigator national si membru in “steering committee” |

| |The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in |

| |High Risk Subjects (SPIRE-1). Protocol No. B1481022 (2013- 2017). Investigator national si membru in “steering |

| |committee” |

| |The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in|

| |High Risk Subjects (SPIRE-2). Protocol No. B1481038 (2013- 2017). Investigator national si membru in “steering |

| |committee” |

|ANEXE |[pic] |

| |Lista de lucrări/publicaţii (selectie pentru ultimii 7 ani) |

1. Andrei G Dan: Atrial Fibrillation therapy . 1st edited by G.A. Dan, A. Bayes de Luna, John Camm, 01/2014; Springer., ISBN: 978-1-4471-5474-7

2. Andrei G Dan: Changing the Paradigm to Understand and Manage Atrial Fibrillation. Atrial Fibrillation Therapy, 1 edited by G.A. Dan, A.Bayes de Luna, J. Camm, 01/2014: chapter 6: pages 127-164; Springer Verlag London., ISBN: 978-1-4471-5474-7

3. Andrei G Dan: Guidelines and current reccommendations in atrial fibrilation. Atrial Fibrillation Therapy, 1 edited by G.A. Dan, A Bayes de Luna, J. Camm, 01/2014: chapter 7: pages 165-180; Springer Verlag London., ISBN: 978-1-4471-5474-7

4. Andrei.G. Dan, Anca Dan, P. Manu, Drug induced Torsade de Pointes and sudden cardiac death in "Life-Threatening Effects of Antipsychotic Drugs" (P. Manu, R.J. Flanagan and KJ Ronaldson, Editors); 2016 Elsevier Inc.; ISBN: 978-0-12-803376-0

5. C.A.Buzea, A.R.Dan, G.A.Dan, Exercitii electrocardiografice. Editura Medicala Antaeus 2016; ISBN: 978-606-8470-19-1

6. Gh.-A. Dan, A.Dan, Moartea subita cardiaca. In "Urgente Medicale" (sub redactia M. Dorobantu); 2017 Editura Medicala; ISBN: 978-973-39-0830-2

7. A. Dan, Gh.-A. Dan, Sincopa. In "Urgente Medicale" (sub redactia M. Dorobantu); 2017 Editura Medicala; ISBN: 978-973-39-0830-2

8. Coordonator si autor pentru capitolele: Boli valvulare, Insuficienta cardiaca, Sindromul de apnee in somn, Cardiomiopatii, Pericardite. Manual de Semiologie pentru anul III, vol. 2 (sub redactia Ion Dina) 2018 Editura Universitara "Carol Davila"; ISBN: 978-606-011-002-6

9. Gh.-A. Dan, C.A. Buzea, Paced rhythms and device troubleshooting, Section 12, in "ECG Masters' Collection. Volume2" (M. Shenasa, M.E. Josephson, N.A. Mark Estes III, E.A. Amsterdam, M. Scheinman, Editors); 2018 Cardiotext Publishing; ISBN: 978-1-942909-20-0

10. G.-A. Dan, J. Steffel, Atrial Fibrillation in Cardiovascular pharmacotherapy, ESC Handbook, 2019, ed. Oxford, ISBN 978– 0– 19– 875993– 5

11. Christian Sticherling, Francisco Marin, David Birnie, Giuseppe Boriani, Hugh Calkins, Gheorghe-Andrei Dan, Michele Gulizia, Sigrun Halvorsen, Gerhard Hindricks, Karl-Heinz Kuck, Angel Moya, Tatjana Potpara, Vanessa Roldan, Roland Tilz, Gregory Y H Lip, Bulent Gorenek, Julia H Indik, Paulus Kirchhof, Chang-Shen Ma, Calambur Narasimhan, Jonathan Piccini, Andrea Sarkozy, Dipen Shah, Irene Savelieva: Antithrombotic management in patients undergoing electrophysiological procedures: A European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace 06/2015; 17(8). DOI:10.1093/europace/euv190

12. Giuseppe Boriani, Irina Savelieva, Gheorghe-Andrei Dan, Jean Claude Deharo, Charles Ferro, Carsten W Israel, Deirdre A Lane, Gaetano La Manna, Joseph Morton, Angel Moya Mitjans, Marc A Vos, Mintu P Turakhia, Gregory Y.H. Lip, Bulent Gorenek, Yoshihide Takahashi, Dennis Lau, Mina Chung, Jens Cosedis Nielsen, Laurent Fauchier, Tatjana Potpara, Francisco Marin, Gulmira Kudaiberdieva, Gerhard Hindricks, Cecilia Linde, Michele Brignole: Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: Clinical significance and implications for decision making- A position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 06/2015; 17(8). DOI:10.1093/europace/euv202

13. Rose Anne Kenny, Michele Brignole, Gheorghe-Andrei Dan, Jean Claude Deharo, J Gert van Dijk, Colin Doherty, Mohamed Hamdan, Angel Moya, Steve W Parry, Richard Sutton, Andrea Ungar, Wouter Wieling, Mehran Asgari, Gonzalo Baron-Esquivias, Jean-Jacques Blanc, Ivo Casagranda, Conal Cunnigham, Artur Fedorowski, Raffello Furlan, Nicholas Gall, Frederik J De Lange, Geraldine Mcmahon, Peter Mitro, Artur Pietrucha, Cristian Podoleanu, Antonio Raviele, David Benditt, Andrew Krahn, Carlos Arturo Morillo, Brian Olshansky, Satish Raj, Robert Sheldon, Win Kuang Shen, Benjamin Sun, Denise Hachul, Haruhiko Abe, Toshyuki Furukawa, Bulent Gorenek, Gregory Y H Lip, Michael Glikson, Philippe Ritter, Jodie Hurwitz, Robert Macfadyen, Andrew Rankin, Luis Mont, Jesper Svendsen, Fred Kusumoto, Mitchell Cohen, Irene Savelieva: Syncope Unit: rationale and requirement – the European Heart Rhythm Association position statement endorsed by the Heart Rhythm Society. Europace 06/2015; DOI:10.1093/europace/euv115

14. Deirdre A. Lane, Luis Aguinaga, Carina Blomström-Lundqvist, Giuseppe Boriani, Gheorge-Andrei Dan, Mellanie True Hills, Elaine M. Hylek, Stephen A. LaHaye, Gregory Y.H. Lip, Trudie Lobban, John Mandrola, Pamela J. McCabe, Susanne S. Pedersen, Ron Pisters, Simon Stewart, Kathryn Wood, Tatjana S. Potpara, , Bulent Gorenek, Jamie Beth Conti, Roberto Keegan, Suzannah Power, Jeroen Hendriks, Philippe Ritter, Hugh Calkins, Francesco Violi, Jodie Hurwitz. Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace (2015)17,1747–1769; DOI: 1747-1769

15. Demosthenes G Katritsis, Giuseppe Boriani, Francisco G Cosio, Gerhard Hindricks, Pierre Jaïs, Mark E Josephson, Roberto Keegan, Young-Hoon Kim, Bradley P Knight, Karl-Heinz Kuck, Deirdre A Lane, Gregory Y H Lip, Helena Malmborg, Hakan Oral, Carlo Pappone, Sakis Themistoclakis, Kathryn A Wood, Carina Blomström-Lundqvist, Bulent Gorenek, Nikolaos Dagres, Gheorge-Andrei Dan, Marc A Vos, Gulmira Kudaiberdieva, Harry Crijns, Kurt Roberts-Thomson, Yenn-Jiang Lin, Diego Vanegas, Walter Reyes Caorsi, Edmond Cronin, Jack Rickard: European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). Europace 11/2016;DOI:10.1093/europace/euw301

16. Hypertension and cardiac arrhythmias: A consensus document from the European Heart Rhythm 1 Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-2 Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y 3 Electrofisiología (SOLEACE). Review coordinator: G.A. Dan

17. Nikolaos Dagres, Tze-Fan Chao, Guilherme Fenelon, Luis Aguinaga, Daniel Benhayon, Emelia J Benjamin, T Jared Bunch, Lin Yee Chen, Shih-Ann Chen, Francisco Darrieux, Angelo de Paola, Laurent Fauchier, Andreas Goette, Jonathan Kalman, Lalit Kalra, Young-Hoon Kim, Deirdre A Lane, Gregory Y H Lip, Steven A Lubitz, Manlio F Márquez, Tatjana Potpara, Domingo Luis Pozzer, Jeremy N Ruskin, Irina Savelieva, Wee Siong Teo, Hung-Fat Tse, Atul Verma, Shu Zhang, Mina K Chung, William-Fernando Bautista-Vargas, Chern-En Chiang, Alejandro Cuesta, Gheorghe-Andrei Dan, David S Frankel, Yutao Guo, Robert Hatala, Young Soo Lee, Yuji Murakawa, Cara N Pellegrini, Claudio Pinho, David J Milan, Daniel P Morin, Elenir Nadalin, George Ntaios, Mukund A Prabhu, Marco Proietti, Lena Rivard, Mariana Valentino, Alena Shantsila: European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. Europace 03/2018;DOI:10.1093/europace/euy046

18. Bulent Gorenek, Giuseppe Boriani, Gheorge-Andrei Dan, Laurent Fauchier, Guilherme Fenelon, He Huang, Gulmira Kudaiberdieva, Gregory Y H Lip, Rajiv Mahajan, Tatjana Potpara, Juan David Ramirez, Marc A Vos, Francisco Marin, Carina Blomstrom-Lundqvist, Aldo Rinaldi, Maria Grazia Bongiorni, Elena Sciaraffia, Jens Cosedis Nielsen, Thorsten Lewalter, Shu Zhang, Oswaldo Gutiérrez, Abdel Fuenmayor: European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). Europace 03/2018;DOI:10.1093/europace/euy051

19. Gheorghe-Andrei Dan, Antoni Martinez-Rubio, Stefan Agewall, Giuseppe Boriani, Martin Borggrefe, Fiorenzo Gaita, Isabelle van Gelder, Bulent Gorenek, Juan Carlos Kaski, Keld Kjeldsen, Gregory Y H Lip, Bela Merkely, Ken Okumura, Jonathan P Piccini, Tatjana Potpara, Birgitte Klindt Poulsen, Magdi Saba, Irina Savelieva, Juan L Tamargo, Christian Wolpert, Christian Sticherling, Joachim R Ehrlich, Richard Schilling, Nikola Pavlovic, Tom De Potter, Andrzej Lubinski, Jesper Hastrup Svendsen, Keong Ching, John Lewis Sapp, Carol Chen-Scarabelli, Felipe Martinez: Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace 02/2018;20(5). DOI:10.1093/europace/eux373

20. Michele Brignole, Angel Moya, Frederik J de Lange, Jean-Claude Deharo, Perry M Elliott, Alessandra Fanciulli, Artur Fedorowski, Raffaello Furlan, Rose Anne Kenny, et al: 2018 ESC Guidelines for the diagnosis and management of syncope. European Heart Journal 03/2018; 39(21)., DOI:10.1093/eurheartj/ehy037

21. Giuseppe Boriani, Laurent Fauchier, Luis Aguinaga, James M Beattie, Carina Blomstrom Lundqvist, Ariel Cohen, Gheorghe-Andrei Dan, Simonetta Genovesi, Carsten Israel, Boyoung Joung, Zbigniew Kalarus, Rachel Lampert, Vincenzo L Malavasi, Jacques Mansourati, Lluis Mont, Tatjana Potpara, Andrew Thornton, Gregory Y H Lip, Bulent Gorenek, Francisco Marin, Nikolaos Dagres, Emin Evren Ozcan, Radosław Lenarczyk, Harry J Crijns, Yutao Guo, Marco Proietti, Christian Sticherling, Dejia Huang, James Patrick Daubert, Sean D Pokorney, Michel Cabrera Ortega, Ashley Chin: European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). Europace 06/2018;, DOI:10.1093/europace/euy110

22. Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation. Hober K, ConnollySJ, Kher A, Christory F,Dan GA, et al. Int J Clin Pract 2013; 67/6:516-526

23. Syncope in elderly patients - Is there a place for endomyocardial biopsy? C.A. Buzea, A.R. Dan, G.A. Dan. RomJInternMed 2013: 51/2: 67-71

24. Syncope units in Romania: A necessity. A.R. Dan, C.A. Buzea, G.A. Dan. RomJInternMed 2013: 51/1: 3-8

25. Characteristics of patients with atrial fibrillation and history of stroke or transient ischemic attack – some results from the FACTS database. Popescu R, Dan GA, Buzea A. Rom J Neurol 2013; 12/2: 53-57

26. Incidence and hospitalization rate of syncope in a non-emergency hospital. C.A. Buzea, A.R. Dan, G.A. Dan. Romanian Journal of Neurology/ Revista Romana de Neurologie 01/2013; 12(3):113-117

27. Diagnosis orientation and risk stratification in syncope. Buzea CA, Dan AR, Dan GA. Rom J Neurol 2013; 12/3:105-112

28. Secondary prevention in patients with atrial fibrillation and stroke or transient ischemic attack – an insight from the FACTS programme. Popescu R, Dan GA, Buzea A. Rom J Neurol 2013; 12/3:130-135

29. Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation. K Huber, S J Connolly, A Kher, F Christory, G-A Dan, R Hatala, R G Kiss, B Meier, B Merkely, B Pieske, T Potpara, J Stępińska, N Vene Klun, D Vinereanu, P Widimský. International Journal of Clinical Practice 04/2013; 67(6). DOI:10.1111/ijcp.12147

30. Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial. A. P. Maggioni, S. J. Greene, G. C. Fonarow, M. Bohm, F. Zannad, et al. European Heart Journal 10/2013; 34(40):3117-3127. DOI:10.1093/eurheartj/eht342

31. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Maggioni AP, Anker SD, Dahlström U, Filippatos G, Ponikowski P, Zannad F, Amir O, Chioncel O, et al; Heart Failure Association of the ESC. Eur J Heart Fail. 2013 Oct;15(10):1173-84. doi: 10.1093/eurjhf/hft134.

32. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EuroObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Lip GYH, Laroche C, Dan GA, et al. Europace 2014; 16(3):308-19

33. Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence. Martinez-Rubio A, Dan GA, Kaski JC. Expert Rev Cardiovasc Ther 2014 {early online}: 1-15

34. Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review. P. Balanescu, A. Ladaru, E. Balanescu, C. Baicus, G.A. Dan. Biomarkers, 2014: early online 1-11; ISSN: 1354-750X (print), 1366-5804 (electronic)

35. Real world anti-thrombotic treatment in atrial fibrillation: the EuroObservational Research Programme Atrial Fibrillation General Pilot survey. Lip GYH, Laroche C, Dan GA, et al. Am J Med 2014; online 28 January 2014

36. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the EuroObservational Research Programme Pilot survey on Atrial Fibrillation. Lip GYH, Laroche C, Boriani G, Cimaglia P, Dan GA, et al. Europace 2014: doi:10.1093/europace/euu155

37. Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Gregory Y H Lip, Cécile Laroche, Giuseppe Boriani, Gheorghe-Andrei Dan, Massimo Santini, Zbigniew Kalarus, Lars Hvilsted Rasmussen, Mário Martins Oliveira, Georges Mairesse, Harry J G M Crijns, Emmanouil Simantirakis, Dan Atar, Aldo P Maggioni, Luigi Tavazzi. Europace 08/2014; 17(2). DOI:10.1093/europace/euu201

38. Is there still a place for interleukin-6 in systemic lupus erythematosus?. A. Dima, C. Jurcut, P. Balanescu, E. Balanescu, S. Caraiola, C. Badea, A. Nicolau, R. Ionescu, C. Baicus, G. A. Dan. Wiener klinische Wochenschrift 12/2014; 126

39. P wave signal-averaged electrocardiography in patients with chronic obstructive pulmonary disease. C. A. Buzea, Anca Rodica Dan, Caterina Delcea, M.I. Balea, Daniela Gologanu, Mihaela Dobranici, Raluca Alexandra Popescu, G.A. Dan. Romanian journal of internal medicine 01/2015; DOI:10.1515/rjim-2015-0040

40. Extended antiphospholipid antibodies screening in systemic lupus erythematosus patients. Alina Dima, Simona Caraiola, C. Jurcut, Eugenia Balanescu, P. Balanescu, Doina Ramba, Camelia Badea, V. Pompilian, R. Ionescu, Anda Baicus, C. Baicus, G. A. Dan. Romanian journal of internal medicine 01/2015; DOI:10.1515/rjim-2015-0041

41. Heart failure in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation. Gregory Y.H. Lip, Cécile Laroche, Mircea I Popescu, Lars H Rasmussen, Laura Vitali-Serdoz, Gheorghe-Andrei Dan, Zbigniew Kalarus, Harry J G M Crijns, Mario M Oliveira, Luigi Tavazzi, Aldo P Maggioni, Giuseppe Boriani. European Journal of Heart Failure 03/2015; 17(6). DOI:10.1002/ejhf.254

42. FRI0581 Utility of the Glasgow Prognostic Score in Systemic Lupus Erythematosus, In a Single Center Cohort of 130 Patients. C. Delcea, A. Dima, C. Jurcut, S. Caraiola, C. Badea, D. Nitescu, E. Balanescu, A. Nicolau, V. Pompilian, R. Ionescu, C. Baicus, G.A. Dan. Annals of the Rheumatic Diseases 06/2015; 74(Suppl 2):638.2-638. DOI:10.1136/annrheumdis-2015-eular.6081

43. AB0556 ESR/C3 and Lymphocyte/ESR Ratios – Markers of Disease Activity in Systemic Lupus Erythematosus. C. Delcea, A. Dima, S. Caraiola, C. Jurcut, C. Badea, E. Balanescu, D. Nitescu, A. Nicolau, R. Ionescu, C. Baicus, G.A. Dan. Annals of the Rheumatic Diseases 06/2015; 74(Suppl 2):1086.1-1086. DOI:10.1136/annrheumdis-2015-eular.6001

44. Association of anti phosphatidyl ethanolamine antibodies and low complement levels in systemic sclerosis patients – results of a cross-sectional study. Paul Bălănescu, Anca Lădaru, Eugenia Bălănescu, Cristian Băicuş, Gheorghe Andrei Dan. Scandinavian journal of clinical and laboratory investigation 06/2015; 75(6):1-6. DOI:10.3109/00365513.2015.1050690

45. AB0543 Numerical Rating Scale in Assessing Disease Severity in Systemic Lupus Erythematosus Patients. A. Dima, C. Jurcut, E. Balanescu, S. Caraiola, C. Delcea, D. Nitescu, C. Badea, C. Baicus, G.A. Dan. Annals of the Rheumatic Diseases 06/2015; 74(Suppl 2):1081.2-1081. DOI:10.1136/annrheumdis-2015-eular.5887

46. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: A report from the EORP-AF General Pilot Registry. Gregory Y.H. Lip, Cécile Laroche, Mircea Iaochim Popescu, Lars Hvilsted Rasmussen, Laura Vitali-Serdoz, Gheorghe-Andrei Dan, Zbigniew Kalarus, Harry J.G.M. Crijns, Mario Martins Oliveira, Luigi Tavazzi, Aldo P Maggioni, Giuseppe Boriani. Europace 08/2015; 17(12). DOI:10.1093/europace/euv269

47. Role of signal-averaged electrocardiography and ventricular late potentials in patients with chronic obstructive pulmonary disease. C.A. Buzea, G.A. Dan, Anca Rodica Dan, Caterina Delcea, M.I. Balea, Daniela Stefana Gologanu, Mihaela Dobranici, Raluca Alexandra Popescu. Romanian journal of internal medicine 09/2015; 53(2). DOI:10.1515/rjim-2015-0018

48. Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study. Paul Balanescu, Anca Ladaru, Eugenia Balanescu, Theodor Voiosu, Cristian Baicus,G- A. Dan. Journal of Clinical Laboratory Analysis. Version of Record online: 1 SEP 2015. DOI: 10.1002/jcla.21864

49. Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patients. Andrei M. Voiosu, Ioana C. Daha, Theodor A. Voiosu, Bogdan R. Mateescu, Gheorghe A. Dan, Cristian R. Baicus, Mihail R. Voiosu, Mircea M. Diculescu. Liver International 12/2015; 35/12:2547–2555

50. ‘Real-world’ management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme–Atrial Fibrillation (EORP-AF) General Pilot Registry. Giuseppe Boriani, Cecile Laroche, Igor Diemberger, Elisa Fantecchi, Mircea Ioachim Popescu, Lars Hvilsted Rasmussen, Gheorghe-Andrei Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo P. Maggioni, Gregory Y.H. Lip. Europace 01/2016; DOI:10.1093/europace/euv390

51. Stroke prevention in atrial fibrillation and ‘real world’ adherence to guidelines in the Balkan Region: The BALKAN-AF Survey. Tatjana S. Potpara, Gheorghe-Andrei Dan, Elina Trendafilova et al. Nature Scientific Reports 02/2016; 6:20432. DOI:10.1038/srep20432

52. Deceleration and Acceleration Capacities in Risk Stratification for Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease. Catalin A Buzea, Gheorghe A Dan, Anca R Dan, Caterina Delcea, Marius I Balea, Daniela Gologanu, Raluca A Popescu, Mihaela Dobranici. American journal of therapeutics 05/2016; DOI:10.1097/MJT.0000000000000450

53. Thyroid hormones and the heart. Gheorghe-Andrei Dan. Heart Failure Reviews 04/2016; DOI:10.1007/s10741-016-9555-6

54. Physical activity and major adverse events in patients with atrial fibrillation: a report from the eurobservational research programme pilot survey on atrial fibrillation (eorp-af) general registry. Marco Proietti, Giuseppe Boriani, Cécile Laroche, Igor Diemberger, Mircea I. Popescu, Lars Hvilsted Rasmussen, Gianfranco Sinagra, Georghe-Andrei Dan, Aldo P. Maggioni, Luigi Tavazzi, Deirdre A. Lane, Gregory Lip. Europace 04/2017; 67(13):688. DOI:10.1016/S0735-1097(16)30689-1

55. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation. Marco Proietti, Valeria Raparelli, Cécile Laroche, Georghe-Andrei Dan, Marianna Janion, Raluca Popescu, Gianfranco Sinagra, Johan Vijgen, Giuseppe Boriani, Aldo P. Maggioni, Luigi Tavazzi, Gregory Y.H. Lip: Europace 12/2016;, DOI:10.1093/europace/euw169

56. Following up adult patients with tetralogy of fallot: The role of echocardiography: Echocardiography in Tetralogy of Fallot. Ana Maria Daraban, Ruxandra Jurcuţ, Elisabeta Bădilă, Daniela Bartoş, Gheorghe Andrei Dan: Journal of Clinical Ultrasound 11/2016;, DOI:10.1002/jcu.22411

57. Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. Marco Proietti, Giuseppe Boriani, Cécile Laroche, Igor Diemberger, Mircea I. Popescu, Lars H. Rasmussen, Gianfranco Sinagra, Gheorghe-Andrei Dan, Aldo P. Maggioni, Luigi Tavazzi, Deirdre A. Lane. Europace 06/2016;, DOI:10.1093/europace/euw150

58. Clinical significance of serum and urinary interleukin-6 in systemic lupus erythematosus patients. A. Dima, C. Jurcut, P. Balanescu, E. Balanescu, C. Badea, S. Caraiola, I. Miler, D. Ramba, R. Ionescu, C. Baicus, G.A. Dan, G. Mircescu. Egyptian Rheumatologist 06/2016; 39(1)., DOI:10.1016/j.ejr.2016.05.005

59. Transseptal Leftventricular Endocardial Pacing is an Alternative Technique in Cardiac Resynchronization Therapy. One Year Experience in a High Volume Center. I. Neuhoff, S. Szilágyi, L. Molnár, I. Osztheimer, E. Zima, G.A. Dan, B. Merkely, L. Gellér: Rom J Int Med 06/2016; 54(2)., DOI:10.1515/rjim-2016-0020

60. Cardiovascular Pharmacotherapies Focus Are low doses of direct-acting oral anticoagulants justified and appropriate in patients with nonvalvular atrial fibrillation? Antoni Martinez Rubio, Gheorghe-Andrei Dan. European Cardiology Review, 2016;11(2):115–7. DOI: 10.15420/ecr.2016:11.2:ED2

61. Myocardial ischemia: not always of coronary origin. G.-A. Dan, Anca Dan. Ischemic Heart Disease in Practice 2017

62. Sven Reek, Haran Burri, Paul R. Roberts, Christian Perings, Andrew E. Epstein, Helmut U. Klein, Gregory Lip, Bulent Gorenek, Christian Sticherling, Laurent Fauchier, Andreas Goette, Werner Jung, Marc A. Vos, Michele Brignole, Christian Elsner, Gheorghe-Andrei Dan, Francisco Marin, Giuseppe Boriani, Deirdre Lane, Carina Blomstrom Lundqvist, Irina Savelieva: The wearable cardioverter-defibrillator: Current technology and evolving indications. Europace 03/2017; 19(3):335-345., DOI:10.1093/europace/euw180

63. Richard Češka, Tomáš Freiberger, Andrey V Susekov, György Paragh, Željko Reiner, Lale Tokgözoğlu, Katarína Rašlová, Maciej Banach, Branislav Vohnout, Andrzej Rynkiewicz, Assen Goudev, G.-A. Dan, D. Gaita, Belma Pojskić, Ivan Pećin, Meral Kayıkçıoğlu, Olena Mitchenko, Marat V Ezhov, Gustavs Latkovskis, Žaneta Petrulionienė, Zlatko Fras, Nebojsa Tasić, Erkin M Mirrakhimov, Tolkun Murataliev, Alexander B Shek, Vladimír Tuka, Alexandros D Tselepis, Elie M Moubarak, Khalid Al Rasadi: ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology. Vnitr̆ní lékar̆ství 01/2017; 63(1):25-30.

64. Richard Češka, György Paragh, Željko Reiner, Maciej Banach, Lale Tokgözoğlu, Andrey V Susekov, Katarína Rašlová, Tomáš Freiberger, Branislav Vohnout, Andrzej Rynkiewicz, Assen Goudev, G.-A. Dan, D. Gaita, Belma Pojskić, Ivan Pećin, Meral Kayıkçıoğlu, Olena Mitchenko, Marat V Ezhov, Gustavs Latkovskis, Žaneta Petrulionienė, Zlatko Fras, Nebojsa Tasić, Erkin M Mirrakhimov, Tolkun Murataliev, Alexander B Shek, Vladimír Tuka, Alexandros D Tselepis, Elie M Moubarak, Khalid Al Rasadi: ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design. Vnitr̆ní lékar̆ství 01/2017; 63(1):43-48

65. Gregory Y.H. Lip, Jose L. Merino, G. Andrei Dan, Sakis Themistoclakis, Kenneth A. Ellenbogen, Raffaele De Caterina, Assen Goudev, James Jin, Michael Melino, Shannon M. Winters, Andreas Goette: Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study). The American Journal of Cardiology 11/2017; 121(2)., DOI:10.1016/j.amjcard.2017.10.008

66. Giuseppe Boriani, Marco Proietti, Cécile Laroche, Laurent Fauchier, Francisco Marin, Michael Nabauer, Tatjana Potpara, Gheorghe-Andrei Dan, Zbigniew Kalarus, Igor Diemberger, Luigi Tavazzi, Aldo P Maggioni, Gregory Y H Lip, Orenes-Piñero E, M. Budnik: Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry. Europace 09/2017; 20(5)., DOI:10.1093/europace/eux301

67. G. Andrei Dan: Atrial fibrillation: Applying evidence out of the box. International Journal of Cardiology 09/2017; 243:270-271., DOI:10.1016/j.ijcard.2017.05.089

68. A. Dan, G.A. Dan, J.L. Merino, B. Merkely, J. Jin, M. Melino, S.M. Winters, G.Y.H. Lip, A. Goette: P6367Relation of congestive heart failure history to efficacy and safety of edoxaban for cardioversion of atrial fibrillation: subanalysis from the ENSURE-AF study. European Heart Journal 08/2017; 38(suppl_1-suppl_1):ehx493.P6367., DOI:10.1093/eurheartj/ehx493.P6367

69. Tatjana S. Potpara, Elina Trendafilova, Gheorghe-Andrei Dan, Artan Goda, Zumreta Kusljugic, Sime Manola, Ljilja Music, Viktor Gjini, Belma Pojskic, Mircea Ioakim Popescu, Catalina Arsenescu Georgescu, Elena S. Dimitrova, Delyana Kamenova, Uliks Ekmeciu, Denis Mrsic, Ana Nenezic, Sandro Brusich, Srdjan Milanov, Ivan Zeljkovic, Gregory Y. H. Lip, On behalf of the BALKAN-AF Investigators: The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey. Advances in Therapy 08/2017; 34(1):1-15., DOI:10.1007/s12325-017-0589-5

70. Cristian Baicus, Caterina Delcea, Alina Dima, Emilia Crisan, Ciprian Jurcut, Andrei G. Dan: Influence of decision aids on oral anticoagulant prescribing among physicians: A randomised trial. European Journal of Clinical Investigation 07/2017;, DOI:10.1111/eci.12786

71. Ana Maria Balahura, Andrada Guţă, Vlad Mihalcea, Emma Weiss, Maria Dorobanţu, Daniela Bartoş, Elisabeta Bădilă, Gheorghe Andrei Dan: Pulmonary thromboembolism in an emergency hospital: Are our patients different?. Romanian journal of internal medicine = Revue roumaine de médecine interne 06/2017; 55(4)., DOI:10.1515/rjim-2017-0026

72. T Potpara, E Trendafilova, A Goda, Z Kusljugic, S Manola, L J Music, G A Dan, GYH Lip: P1187Relation of renal function to thromboprophylaxis in non-valvular atrial fibrillation: Insights from the international BALKAN-AF Survey. Europace 03/2018; 20(suppl_1):i230-i230., DOI:10.1093/europace/euy015.671

73. G A Dan, E Badila, E Weiss, C Laroche, G Boriani, A Dan, L Tavazzi, A P Maggioni, H J Crijns, R Popescu, D Blommaert, W Streb, G Y H Lip: Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation. International journal of cardiology 03/2018; 254:136-141., DOI:10.1016/j.ijcard.2017.10.092

74. Gheorghe-Andrei Dan: The net clinical benefit of the antithrombotic protection in prosthetic mechanical valves: Changing the paradigm. International Journal of Cardiology 05/2018; 267, DOI:10.1016/j.ijcard.2018.05.114

75. Tatjana S. Potpara, Gheorghe Andrei‑Dan, Gregory Y.H. Lip: Health care facility type-related challenges in the management of stroke risk in patients with atrial fibrillation: practical implications. Polskie archiwum medycyny wewnȩtrznej 05/2018; 128(5):271-273., DOI:10.20452/pamw.4276

76. Marco Canepa, Candida Fonseca, Ovidiu Chioncel, Cécile Laroche, Maria G Crespo-Leiro, Andrew J S Coats, R. Popescu, I. Daha, G.-A. Dan, C. Stanescu, A. Dan, et al, ESC HF Long Term Registry Investigators: Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry. JACC: Heart Failure 06/2018; 6(6):452-462., DOI:10.1016/j.jchf.2018.02.001

77. C.Delcea, C.A. Buzea, M.I. Balea, D. Gologanu, M. Dobranici, R.A. Popescu, G.A. Dan: FACT – A NEW PREDICTION SCORE FOR SUPRAVENTRICULAR TACHYARRHYTHMIAS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Journal of Hypertension 06/2018; 36:e255-e256., DOI:10.1097/01.hjh.0000539729.65245.eb

78. Kristina H Haugaa, Gheorghe-Andrei Dan, Konstantinos Iliodromitis, Radoslaw Lenarczyk, Germanas Marinskis, Joaquin Osca, Daniel Scherr, Nikolaos Dagres: Management of patients with ventricular arrhythmias and prevention of sudden cardiac death—translating guidelines into practice: results of the European Heart Rhythm Association survey. Europace 06/2018; 20(FI2)., DOI:10.1093/europace/euy112

79. Gheorghe-Andrei Dan, Konstantinos Iliodromitis, Daniel Scherr, Francisco Marín, Radoslaw Lenarczyk, Heidi L Estner, Marcin Kostkiewicz, Nikolaos Dagres, Gregory Y H Lip: Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey. Europace 06/2018; 20(8)., DOI:10.1093/europace/euy094

80. G-A Dan, A Martinez-Rubio: Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from EHRA and ESC WG on Cardiovascular Pharmacology endorsed HRS, APHRS, and ISCP-Authors' reply. Europace 10/2018; 20(11)., DOI:10.1093/europace/euy217

81. Gheorghe-Andrei Dan, Dobromir Dobrev: Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging. IJC heart & vasculature 09/2018; 21:11-15., DOI:10.1016/j.ijcha.2018.08.005

82. C Delcea, C A Buzea, A Tocitu, A Andrus, A Breha, M Dobranici, R Popescu, I Daha, G A Dan: P1825R2CHADS score - better than CHA2DS2-VASc as a predictor of mortality in the patients with heart failure. European Heart Journal 08/2018; 39(suppl_1)., DOI:10.1093/eurheartj/ehy565.P1825

83. S Potpara, G A Dan, Z Kusljugic, V Paparisto, A Goda, E Trendafilova, S Manola, L J Music, N Pavlovic, G Y H Lip: P2911Age-dependency in the implementation of guideline-recommended therapy for stroke prevention in patients with non-valvular atrial fibrillation: insights from the BALKAN-AF Survey. European Heart Journal 08/2018; 39(suppl_1)., DOI:10.1093/eurheartj/ehy565.P2911

84. Giuseppe Boriani, Marco Proietti, Cécile Laroche, Laurent Fauchier, Francisco Marin, Michael Nabauer, Tatjana Potpara, Gheorghe-Andrei Dan, Zbigniew Kalarus, Igor Diemberger, Luigi Tavazzi, Aldo P Maggioni, Gregory Y H Lip, Javier García-Seara: Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry on behalf of the EORP-AF Long-Term General Registry Investigators. Europace 07/2018; 20:747-757., DOI:10.1093/europace/eux301.

85. Giuseppe Boriani, Marco Proietti, Cécile Laroche, Igor Diemberger, Mircea Ioachim Popescu, Sam Riahi, Alena Shantsila, Gheorghe-Andrei Dan, Luigi Tavazzi, Aldo P Maggioni, Gregory Y H Lip: Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry. International journal of cardiology 07/2018; 271., DOI:10.1016/j.ijcard.2018.05.034

86. Mihaela Dobranici, Anamaria Tocitu, Caterina Delcea, Gheorghe-Andrei Dan: Left Ventricular Noncompaction in a Patient with Systemic Lupus Erythematosus. 10/2018;, DOI:10.2478/rjim-2018-0032

87. Dumitrescu A, Mosteoru A, Vinereanu D, Dan G.A., Gaita L, Gaita D. Preliminary data of familial hypercholesterolemia (FH) patients in Romania. Atherosclerosis 277 (2018) 304–307, DOI: 10.1016/j.atherosclerosis.2018.08.015

Oct..2019

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download